Binding of retelliptine, a new antitumoral agent, to serum proteins and erythrocytes
- 15 August 1990
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 40 (4) , 895-898
- https://doi.org/10.1016/0006-2952(90)90333-g
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Interrelationship between affinity for DNA, cytotoxicity and induction of DNA-breaks in cultured L1210 cells for two series of tricyclic intercalators: Simplified analogues of ellipticine derivativesBiochemical Pharmacology, 1989
- Preparation of low density lipoprotein-9-methoxy-ellipticin complex and its cytotoxic effect against L1210 and P 388 leukemic cells in vitroEuropean Journal of Cancer and Clinical Oncology, 1989
- Binding of indapamide to serum proteins and erythrocytesBiochemical Pharmacology, 1988
- Potential antitumor agents. 50. In vivo solid-tumor activity of derivatives of N-[2-(dimethylamino)ethyl]acridine-4-carboxamideJournal of Medicinal Chemistry, 1987
- Auramine O as a fluorescent probe for the binding of basic drugs to human α1-acid glycoprotein (α1-AG) The development of a simple fluorometric method for the determination of α1-AG in human serumBiochemical Pharmacology, 1985
- Effect of membrane potential on the cellular uptake of 2-N-methyl-ellipticinium by L1210 cellsBiochemical Pharmacology, 1984
- Ellipticine-induced alteration of model and natural membranesBiochemical Pharmacology, 1983
- Evidence for binding of certain acidic drugs to α1-acid glycoproteinBiochemical Pharmacology, 1982
- Optical studies on the specific interaction of dipyridamole with α1-acid glycoprotein (orosomucoid)Journal of Pharmacy and Pharmacology, 1982
- Interactions between Ellipticine and Phospholipids. Effect of Ellipticine and 9‐Methoxyellipticine on the Phase Behaviour of PhosphatidylglycerolsEuropean Journal of Biochemistry, 1980